We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Performance data for MHRA key performance indicators (KPIs) and information on the expected timeline to complete a specific regulatory function.
Overview Our 2024/25 business plan gave a commitment to our focus being…
Information on how the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG) is controlling spend on branded medicines in the NHS.
Measured sales held February 2025 Table 1A: measured sales reported under…
Measured sales November 2024 Table 1A: measured sales reported under the…
A programme to help decision making across the lifecycle of products, benefitting both regulatory and health technology assessment (HTA) evaluations.
This report examines three innovative projects funded through the Veterans’ Health Innovation Fund competition
MHRA performance metrics for clinical trials and established medicines assessment.
Progress made in delivering the Patient Involvement Strategy, October 2021 - January 2025.
Minutes of a meeting held between the government, NHS England and ABPI about the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG).
Information on how the 2019 voluntary scheme for branded medicines pricing and access (VPAS) controlled spend on branded medicines in the NHS between 2019 and 2023.
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 20 September 2022 and 5 May 2023.
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 1 June 2021 and 19 November 2021.
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 3 December 2021 and 29 March 2022.
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 13 April 2022 and 25 August 2022.
Information on Medicines and Healthcare products Regulatory Agency spending over £25,000.
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 10 May 2021 to 25 May 2021.
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 13 January 2021 to 15 February 2021.
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 25 February 2021 to 6 April 2021.
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 25 August 2020 to 28 November 2020.
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 12 April 2021 to 4 May 2021.
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 7 December 2020 to 3 January 2021.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).